Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
S&P Global
SPGI
|
+$1.3B |
| 2 |
Johnson Controls International
JCI
|
+$1.09B |
| 3 |
Coupang
CPNG
|
+$901M |
| 4 |
Baxter International
BAX
|
+$822M |
| 5 |
Mastercard
MA
|
+$808M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.81B |
| 2 |
Deere & Co
DE
|
+$1.36B |
| 3 |
Coca-Cola
KO
|
+$1.14B |
| 4 |
Comcast
CMCSA
|
+$1.07B |
| 5 |
Abbott
ABT
|
+$990M |
Sector Composition
| 1 | Healthcare | 21.97% |
| 2 | Technology | 17.32% |
| 3 | Financials | 14.67% |
| 4 | Industrials | 10.75% |
| 5 | Consumer Discretionary | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Agilysys
AGYS
$3.08B
| $23.5M | ﹤0.01% |
489,283
+203,493
| +71% | +$9.76M |
|
1027
XPeng
XPEV
$19.6B
| $23.3M | ﹤0.01% |
638,583
-80,668
| -11% | -$2.95M |
|
1028
Cytokinetics
CYTK
$6.24B
| $23.2M | ﹤0.01% |
996,277
-180,518
| -15% | -$4.2M |
|
1029
Warrior Met Coal
HCC
$3.11B
| $23.2M | ﹤0.01% |
1,352,611
-11,533
| -0.8% | -$198K |
|
1030
Porch Group
PRCH
$1.86B
| $23.2M | ﹤0.01% |
1,308,349
-965,315
| -42% | -$17.1M |
|
1031
Pediatrix Medical
MD
$1.46B
| $23.1M | ﹤0.01% |
+906,084
| New | +$23.1M |
|
1032
Edgewise Therapeutics
EWTX
$1.53B
| $23.1M | ﹤0.01% |
+742,412
| New | +$23.1M |
|
|
MNRL
1033
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $22.9M | ﹤0.01% |
1,561,595
-185,459
| -11% | -$2.72M |
|
1034
Armstrong World Industries
AWI
$8.58B
| $22.8M | ﹤0.01% |
253,438
+27,969
| +12% | +$2.52M |
|
1035
Perella Weinberg Partners
PWP
$1.43B
| $22.8M | ﹤0.01% |
2,037,403
+1,712,403
| +527% | +$19.1M |
|
1036
VEON
VEON
$3.72B
| $22.5M | ﹤0.01% |
507,675
-21,957
| -4% | -$972K |
|
1037
ProQR Therapeutics
PRQR
$228M
| $22.4M | ﹤0.01% |
3,394,246
-61,519
| -2% | -$407K |
|
1038
MVB Financial
MVBF
$306M
| $22.4M | ﹤0.01% |
662,002
+188,037
| +40% | +$6.36M |
|
1039
Colliers International
CIGI
$8.58B
| $22.3M | ﹤0.01% |
+227,384
| New | +$22.3M |
|
1040
RAPT Therapeutics
RAPT
$250M
| $22.3M | ﹤0.01% |
125,497
-26,277
| -17% | -$4.67M |
|
1041
Liberty Media Series C
FWONK
$25B
| $22.2M | ﹤0.01% |
529,557
+2,136
| +0.4% | +$89.4K |
|
1042
Fabrinet
FN
$13.3B
| $22.2M | ﹤0.01% |
245,187
-58,608
| -19% | -$5.3M |
|
|
PDCE
1043
DELISTED
PDC Energy, Inc.
PDCE
| $22.1M | ﹤0.01% |
641,204
-135,980
| -17% | -$4.68M |
|
1044
AbbVie
ABBV
$389B
| $22M | ﹤0.01% |
203,659
-26,017
| -11% | -$2.82M |
|
1045
Astec Industries
ASTE
$1.08B
| $21.8M | ﹤0.01% |
288,722
+56,440
| +24% | +$4.26M |
|
1046
Mercury Systems
MRCY
$4.42B
| $21.7M | ﹤0.01% |
307,789
+4,966
| +2% | +$351K |
|
1047
Rhythm Pharmaceuticals
RYTM
$6.65B
| $21.6M | ﹤0.01% |
1,015,302
-1,085,925
| -52% | -$23.1M |
|
1048
Nucor
NUE
$33B
| $21.5M | ﹤0.01% |
267,431
-113,657
| -30% | -$9.12M |
|
1049
Q32 Bio
QTTB
$22.4M
| $21.4M | ﹤0.01% |
126,551
+7,496
| +6% | +$1.27M |
|
|
TBA
1050
DELISTED
Thoma Bravo Advantage
TBA
| $21.3M | ﹤0.01% |
+2,037,604
| New | +$21.3M |
|